Early-onset therapy with sirolimus helps to improve prognosis of patients with lymphangioleiomyomatosis (LAM) Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019
Long-term sirolimus treatment in lymphangioleiomyomatosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism Source: Eur Respir J 2016; 48: 1360-1368 Year: 2016
Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017
Prolonged sirolimus therapy in advanced pulmonary lymphangioleiomyomatosis; a multicenter French experience Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy Source: Eur Respir J 2004; 24: Suppl. 48, 478s Year: 2004
Outcomes of patients on multiple vasopressor therapy Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010
Multiple organ leiomyomatosis in patients with pulmonary lymphangioleiomyomatosis and experience of treatment with Zoladex, a depot of gonadotropin-releasing hormone agonist Source: Eur Respir J 2003; 22: Suppl. 45, 48s Year: 2003
Efficacy of traditional and combined therapy in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 234s Year: 2003
Combination therapy may be beneficial for the treatment of lymphangioleiomyomatosis Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013
Treatment with low-dose everolimus in patients with sporadic lymphangioleiomyomatosis (LAM) Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014
Long-term treatment with infliximab in patients with sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
First-line therapy Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Doxycicline in the treatment of lymphangioleiomyomatosis Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010
Clinical experience in surgical therapy of 184 patients with bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 626s Year: 2004
High-doses glucocorticosteroid treatment in sarcoidosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 118s Year: 2007
Insomnia in chemotherapy patients Source: Breathe 2010; 6: 370-371 Year: 2010
Clinical experience in surgical therapy of 257 patients with bronchiectasis Source: Annual Congress 2007 - Surgical management of thoracic infections and issues in respiratory physiology Year: 2007